Nomura, CLSA, HSBC and Jefferies maintained their ‘buy’ rating on the stock, while JPMorgan, Macquarie and Morgan Stanley retained their outperform outlook on the stock. These brokerages expect the stock to rise between 6% and 17% from their respective price forecasts.
US stocks: US market ends lower as tech stocks weigh on sentiment
Wall Street ended lower on Friday, with AI chip stocks experiencing a significant downturn while Moderna and other healthcare companies surged. Investors are weighing the